Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

We came across a bullish thesis on Medtronic plc (MDT) on Investing Intel’s Substack. In this article, we will summarize the ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 ...

After a three-year drought, the industry is questioning whether the window for medtech public offerings is open following a ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Medtronic’s stock has experienced a notable decline of 7.23% over the past week, despite the company’s recent earnings call highlighting strong revenue growth in key segments ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, expects the India infusion pumps market size to grow at a CAGR of 8.26% during the forecast period between ...